At a glance
- Originator Yamanouchi
- Class Laxatives
- Mechanism of Action Serotonin 3 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Constipation
Most Recent Events
- 29 Feb 2000 No-Development-Reported for Constipation in Japan (Unknown route)
- 06 Mar 1997 New profile
- 06 Mar 1997 Preclinical development for Constipation in Japan (Unknown route)